APA

Vergnenegre A., Monnet I., Bizieux A., Bernardi M., Chiapa A. M., Léna H., Chouaïd C. & Robinet G. (20201005). Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC. : Future oncology (London, England).

Chicago

Vergnenegre Alain, Monnet Isabelle, Bizieux Acya, Bernardi Marie, Chiapa Anne Marie, Léna Hervé, Chouaïd Christos and Robinet Gilles. 20201005. Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC. : Future oncology (London, England).

Harvard

Vergnenegre A., Monnet I., Bizieux A., Bernardi M., Chiapa A. M., Léna H., Chouaïd C. and Robinet G. (20201005). Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC. : Future oncology (London, England).

MLA

Vergnenegre Alain, Monnet Isabelle, Bizieux Acya, Bernardi Marie, Chiapa Anne Marie, Léna Hervé, Chouaïd Christos and Robinet Gilles. Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC. : Future oncology (London, England). 20201005.